Vivanza Biosciences Submits SEBI Confirmation Certificate for Q4 FY26

Vivanza biosciences Limited has fulfilled its regulatory compliance requirements by submitting the mandatory confirmation certificate under SEBI regulations for the fourth quarter of fiscal year 2026. The pharmaceutical company, based in Ahmedabad, completed this filing as part of its ongoing regulatory obligations to the stock exchanges.

Regulatory Compliance Filing

The company submitted its confirmation certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 to BSE Limited on April 7, 2026. This quarterly filing covers the period ended March 31, 2026 and was signed by Company Secretary Chaitra Arora.

Filing Details:	Information
Filing Date:	April 7, 2026
Quarter Covered:	Q4 FY26 (ended March 31, 2026)
Regulation:	SEBI Regulation 74(5)
Authorized Signatory:	Chaitra Arora, Company Secretary

Registrar and Transfer Agent Confirmation

Purva Sharegistry (I) Private Limited, serving as the company's Registrar and Share Transfer Agent, issued the confirmation certificate on April 1, 2026. The RTA holds SEBI registration number INR000001112 and operates as a Category 1 Registrar for IPOs and Share Transfer services.

The certificate confirms compliance with SEBI regulations regarding the processing of securities received from depository participants for dematerialization during the quarter. Ms. Deepali Gaonkar, Compliance Officer at Purva Sharegistry, signed the confirmation document.

Dematerialization Activity Report

The detailed dematerialization report for the period from January 1, 2026 to March 31, 2026 shows no activity during the quarter. The report indicates that no share certificates were processed for dematerialization during this period.

Dematerialization Summary:	Q4 FY26
Period Covered:	January 1, 2026 to March 31, 2026
Certificates Processed:	NIL
Shareholders Involved:	NIL
Total Shares Dematerialized:	NIL

This quarterly filing demonstrates Vivanza Biosciences' commitment to maintaining regulatory compliance and transparent reporting to market participants and regulatory authorities.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-2.39%	+6.81%	+0.99%	+3.03%	-10.53%	-83.00%

Vivanza Biosciences Limited has announced the resignation of Mr. Hemant Amrish Parikh as Non-Executive Director, effective March 17, 2026. The company informed BSE Limited about this board change in compliance with regulatory disclosure requirements under SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Director Resignation Details

Mr. Hemant Amrish Parikh, holding Director Identification Number 00027820, submitted his resignation letter on March 17, 2026, citing personal reasons for his departure. The resignation became effective from the close of business hours on the same date.

Parameter:	Details
Director Name:	Mr. Hemant Amrish Parikh
DIN:	00027820
Position:	Non-Executive Director
Resignation Date:	March 17, 2026
Reason:	Personal reasons
Effective From:	Close of business hours, March 17, 2026
Scrip Code:	530057
ISIN:	INE984E01035

Regulatory Compliance and Documentation

The company has fulfilled its disclosure obligations under Regulation 30 of SEBI Listing Regulations, referencing SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026, last amended on January 30, 2026. As part of the regulatory filing, Vivanza Biosciences provided comprehensive details about the directorial change to BSE Limited, including the reason for cessation and effective date.

The resignation letter was signed by Mr. Parikh from his residence at B-1, 1st Floor, Opp. Gurudwara, Bodakdev, Ahmedabad - 380054. He specifically requested the company to acknowledge receipt and submit necessary forms with the Registrar of Companies for immediate relief from his directorial duties.

Material Reasons Confirmation

Importantly, Mr. Hemant Amrish Parikh confirmed to the company that there are no material reasons for his resignation other than the personal reasons mentioned in his resignation letter dated March 17, 2026. This confirmation was included as part of the regulatory disclosure to ensure transparency with stakeholders.

The announcement was digitally signed by Managing Director Jayendra Amichand Mehta (DIN: 08210602) on March 17, 2026, at 14:18:21 +05'30' on behalf of Vivanza Biosciences Limited. The company's registered office is located at 403, Sarthik 2, Opp. Rajpath Club, S. G. Highway, Ahmedabad 380054, and it operates under CIN: L24105GJ1982PLC005057.